GFA
PLSE icon

Godfrey Financial Associates’s Pulse Biosciences PLSE Stock Holding History

Godfrey Financial Associates’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Hold
1
– – ﹤0.01% 1074
2026
Q1 		$29 Hold
1
– – ﹤0.01% 1097
2025
Q4 		$19 Buy
+1
New +$16 ﹤0.01% 1097

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Godfrey Financial Associates's PLSE Position: Q2 2026 in Review

Godfrey Financial Associates held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 1 share worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Godfrey Financial Associates first reported a position in PLSE in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Godfrey Financial Associates held 1 share of Pulse Biosciences worth $38 as of Q2 2026.
  • Godfrey Financial Associates left its Pulse Biosciences share count unchanged in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #1074 holding.
  • Godfrey Financial Associates first reported a position in Pulse Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.